Skip to main content
. Author manuscript; available in PMC: 2010 Nov 1.
Published in final edited form as: Breast Cancer Res Treat. 2010 Feb 24;124(1):195–203. doi: 10.1007/s10549-010-0799-x

Table 1.

Characteristics of women with a RRSO performed 2001–2008 after disclosure of a positive BRCA1/2 test

Variable Total sample
BRCA1
BRCA2
OOC (N = 16) No ovarian cancer (N = 631) P-value OOC (N = 12) No ovarian cancer (N = 376) P-value OOC (N = 4) No ovarian cancer (N = 255) P-value
Mean birth year (range) 1951 (1928–1967) 1957 (1927–1978) 0.007 1955 (1944–1967) 1958 (1927–1978) 0.175 1941 (1928–1949) 1955 (1929–1971) 0.001
Mean age at RRSO, years (range) 51.7 (35.6–76.4) 46.6 (25.8–75.3) 0.017 48.1 (35.6–60.4) 45.4 (25.8-75.3) 0.249 62.4 (56.1–76.4) 48.4 (33.1–72.9) 0.001
Mean RRSO year (range) 2003 (2001–2005) 2003 (2001–2008) 0.231 2003 (2001–2005) 2003 (2001–2007) 0.433 2003 (2001–2005) 2004 (2001–2008) 0.393
Parous (%) 11 (69%) 413 (78%) 0.378 7 (58%) 244 (78%) 0.156 4 (100%) 169 (77%) 0.577
Mean number of live births (range) 2.1 (2–3) 2.5 (2–8) 0.094 2.1 (2–3) 2.5 (2–5) 0.226 2 (2–2) 2.5 (2–8) 0.244
Ever user of oral contraceptives (%) 9 (60%) 466 (82%) 0.046 8 (73%) 283 (84%) 0.395 1 (25%) 183 (78%) 0.039
Ever smoker (%) 9 (60%) 246 (42%) 0.190 9 (75%) 146 (42%) 0.036 0 100 (41%) 0.273*
Breast cancer diagnosis prior to RRSO (%) 8 (50%) 355 (56%) 0.621 5 (42%) 209 (56%) 0.387 3 (75%) 146 (57%) 0.639
Mean age at breast cancer diagnosis (range) 42.6 (28.0–55.2) 42.2 (24.3–70.6) 0.886 37.9 (28.0–55.2) 40.2 (24.3–60.0) 0.475 50.4 (48.5–52.0) 44.9 (25.7–70.6) 0.233
Mean time from genetic testing to RRSO 0.86 (0.003–6.12) 1.01 (0–9.14) 0.679 0.94 (0.003–6.12) 1.03 (0–9.13) 0.835 1.10 (0.06–3.07) 1.39 (0.01–8.48) 0.833
*

Exact confidence levels not possible with zero count cells